Author:
Blandford Alexander D.,Ansari Waseem,Young Jason M.,Maley Bruce,Plesec Thomas P.,Hwang Catherine J.,Perry Julian D.
Funder
National Eye Institute
Research to Prevent Blindness
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. ASDS survey: seven out of ten consumers considering cosmetic procedures.
https://www.asds.net/2017-consumer-survey/
. Accessed 27 Jan 2018
2. Dayan SH, Humphrey S, Jones DH et al (2016) Overview of ATX-101 (deoxycholic acid injection): a nonsurgical approach for reduction of submental fat. Dermatol Surg 42(Suppl 1):S263–S270
3. Fagien S, Mcchesney P, Subramanian M et al (2016) Prevention and management of injection-related adverse effects in facial aesthetics: considerations for ATX-101 (deoxycholic acid injection) treatment. Dermatol Surg 42(Suppl 1):S300–S304
4. Jones DH, Carruthers J, Joseph JH et al (2016) REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction. Dermatol Surg 42(1):38–49
5. Rotunda AM, Suzuki H, Moy RL et al (2004) Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 30(7):1001–1008
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献